COMMUNIQUÉS West-GlobeNewswire

-
23andMe Announces FDA Clearance of IND Application for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6
31/01/2024 -
Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
31/01/2024 -
Protara Therapeutics to Participate in Upcoming Investor Conferences
31/01/2024 -
Agrify Receives Positive Nasdaq Listing Determination
31/01/2024 -
Biogen to Realign Resources for Alzheimer's Disease Franchise
31/01/2024 -
Plus de capacités en faveur des clients : Olon va ouvrir une nouvelle unité de production d'IPA hautement actifs aux États-Unis
31/01/2024 -
Trinity Biotech Announces Q3 2023 Financial Results & Business Update
31/01/2024 -
Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India
31/01/2024 -
SpringWorks Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
31/01/2024 -
Orange Grove Bio Sets Sights on Rapidly Emerging Middle East Biotech Ecosystem through New Academic Collaboration with Weizmann Institute of Science
31/01/2024 -
PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024
31/01/2024 -
EyePoint Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
31/01/2024 -
Tango Therapeutics to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
31/01/2024 -
Tilray Beers: A Lock for the Big Game
31/01/2024 -
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
31/01/2024 -
NC AMVETS Service Foundation Launches CBD Study for Veterans with University of Northern Colorado and Vantage Hemp Co.
31/01/2024 -
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.
31/01/2024 -
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat CKD
31/01/2024 -
Tonix Pharmaceuticals Announces Research Indicating Pre-Existing Fibromyalgia-Type Symptoms May Increase the Risk of Developing Long COVID
31/01/2024
Pages